Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
In honor of LGBT Pride Month, we are pleased to share a blog post from Andrew Petroll, MD, MS is Associate Professor of Medicine (Division of Infectious Diseases) at the Medical College of Wisconsin (MCW).
Views represented here are those of the authors and may not reflect those of PhRMA.
Earlier this month, the health system in Milwaukee where I practice, Froedtert & the Medical College of Wisconsin health network, announced plans for an Inclusion Health Clinic, a clinic designed to offer a wide range of health care services to lesbian, gay, bisexual, transgender and queer (LGBTQ) individuals. Opening this clinic is an important step toward ensuring that LGBTQ individuals have access to health care and health care professionals that both welcome and affirm them as individuals, as well as understand the health disparities faced by this population and offer the preventive measures and medical care that can improve their health outcomes.
Research shows that people in the U.S. who identify as LGBTQ experience multiple health disparities, including higher rates of HIV, obesity and its complications, tobacco use and its complications, depression and suicide and alcohol and recreational drug dependence than those found in the general population. However, research has also demonstrated LGBTQ individuals are less likely to seek or receive health care than their heterosexual counterparts. LGBTQ individuals report avoidance of health care providers and facilities due to perceived or actual experiences of culturally insensitive or medically incompetent care, and even outright discrimination in health care settings. Thus, LGBTQ populations simultaneously may have a higher need for health care services than non-LGBT individuals, yet are less likely to seek or receive them.
Improving the health outcomes of LGBTQ individuals depends on factors relating to the health care environment. This may include implementation of policies that prevent discrimination against LGBTQ persons within health care settings, and developing clinical environments that welcome and affirm LGBTQ patients. Cultural humility – the concept of using a humble and respectful attitude toward each patient, understanding that one cannot know everything about all cultures, but making continued learning about other cultures an ongoing goal – can be an essential step in the development of a strong patient-provider relationship. This sets the stage for the patient to share essential information about themselves, their identity, and their behaviors that allows the provider, with the proper knowledge base, to deliver appropriate preventive care, perform needed diagnostic testing, and to assess a patient’s adherence to recommended treatments.
In addition, to having an approach that allows for easy interactions with LGBTQ patients, providers must also possess the medical knowledge necessary to care for them. Examples of such knowledge include knowing that vaccinations against hepatitis A and human papillomavirus are indicated in some men who have sex with men and understanding how to prescribe gender affirming hormone therapy for transgender patients.
GLMA: Health Professionals Advancing LGBT Equality is an organization dedicated to improving LGBTQ health through advocacy for policies that promote nondiscrimination in health care and enhance provider competency, educational opportunities for health professionals in training and current practitioners, and connecting LGBTQ individuals to competent health care providers through our extensive national Provider Directory. Educational resources for health care professionals interested in improving their competency in caring for LGBTQ patients include GLMA’s Annual Conference on LGBTQ Health, GLMA’s Top 10 LGBT Health Issues, and extensive online training available through the National LGBT Health Education Center.
Andrew Petroll, MD, MS is Associate Professor of Medicine (Division of Infectious Diseases) at the Medical College of Wisconsin (MCW). His clinical practice focuses on the treatment and prevention of HIV. He is also the medical director of the Inclusion Health Clinic at Froedtert & the Medical College of Wisconsin. Dr. Petroll is Associate Professor of Psychiatry and Behavioral Medicine at MCW’s Center for AIDS Intervention Research. His research is aimed at increasing the delivery of HIV prevention services within healthcare settings and the development and testing of multi-level HIV prevention interventions for individuals and communities at risk for HIV acquisition. Dr. Petroll serves as a board member and the Treasurer of GLMA: Health Professionals Advancing LGBT Equality.
Guest Contributor
The PhRMA blog welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view on issues facing our industry and the health care system.
Guest Contributor
Health care practitioners sound the alarm on middlemen-imposed barriers to patient care, need for policy change
Three things to know about the United Nations’ new HIV/AIDS report
Case study: How seniors could face access disruptions because of the IRA’s price setting provisions
ICYMI: Misaligned policies undermine patient access
3 Takeaways from POLITICO’s Health Care Summit
Watch: Putting patients front and center for World AIDS Day
New analysis of patient access restrictions in the United Kingdom
ICYMI: 3 takeaways on the IRA’s unintended consequences from America’s Physician Groups’ 2023 annual fall conference
Navigating the Patient Experience Survey: Protecting Lifelines to Access and Innovation
States can support access to medicine as COVID-19 Public Health Emergency ends
Minnesota lawmakers are letting PBMs off the hook, and threatening patients’ access to medicines
In their own words: Insured Americans support policy reforms that address access and affordability concerns
Making coupons count for patients with HIV
CMS coverage decision restricts access to treatments for Alzheimer’s disease
Report finds PBMs are increasingly restricting patient access to medicines
World AIDS Day: Remembering those we’ve lost and exploring the continued fight against HIV/AIDS
Getting the 340B program back on track in 2021
Action needed to preserve the six protected classes
Study finds biopharmaceutical innovation is responsible for 35% of the increase in life expectancy from 1990 to 2015
Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments
Growth in innovative, value-based contracts holds promise for the health system and for patients
Innovative contracts drive access for patients and value for the system
Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas
ICYMI: Patients saved nearly $800,000 out of pocket through innovative contracting arrangements
PhRMA comments on HHS proposed rule on manufacturer cost-sharing assistance and accumulator adjustment programs
Addressing barriers that inhibit value-based contracts
New data show how ICER’s value framework could prevent or delay access to treatments for Medicaid patients across the country
Guest Post: Following my stroke, having access to ground-breaking medical innovation has never been more important
Setting the record straight on international reference pricing
Fact Check: How the Part B International Pricing Index model threatens patient access
New analysis shows 820,000 prescriptions would be in jeopardy if ICER’s value framework is used in Medicaid
Changes to the six protected class policy are the wrong prescription for Medicare and HIV patients
PhRMA comments to administration on Medicare Part D proposed rule
ICYMI: New study reinforces dangers of proposed IPI model
World AIDS Day 2018: Hope for the future
Groups sound the alarm on administration’s new Part B proposal
4 things you need to know about the administration’s latest Part B proposal
PhRMA submission to the 2019 National Trade Estimate Report urges action to protect U.S. biopharmaceutical innovation
How much do you know about Medicare Part B?
ICER’s budget impact threshold: Sounding a false alarm on affordability and access
PhRMA submission to HHS on blueprint to lower drug prices and reduce out-of-pocket costs
Event next week: Supporting the next generation of lifesaving medicines
Diversity of thought fuels next generation of breakthroughs
New analysis shows that more medicines worldwide are available to U.S. patients
New analysis shows that HTA organizations may frequently restrict access to cancer treatments
New analysis shows negative impact of ICER’s value framework on patient access in Medicare Part B
Event tomorrow: Improving patient access to lifesaving medicines
Event tomorrow: Making the biopharmaceutical supply chain work for patients
PPA celebrates 13 years of helping patients access their medicines
Copay coupons can help ease patients’ out-of-pocket costs
PhRMA launches new consumer-facing Let’s Talk About Cost website
World AIDS Day 2017: Scientific breakthroughs paving the way for an AIDS-free generation
Video: What is a results-based contract?
How much are hospitals marking up the price of medicines? The answer may surprise you.
More than 50 medicines and vaccines in development for HIV infection, treatment and prevention
Foreign government price setting by any name harms innovation and access to medicines
Compulsory licensing: A misused and abused international trade law
ICYMI: New study shows medicines advance life expectancy for HIV patients
Government-imposed price controls threaten innovation and access
Biopharmaceutical industry’s success reducing disparities for African Americans
Medicare Monday: What is IPAB, and why is it bad for patients?
Guest post: Excellent care for LGBTQ patients requires cultural humility and specific medical knowledge
Access
HIVAIDS
Guest post: Excellent care for LGBTQ patients requires cultural humility and specific medical knowledge
Guest post: Excellent care for LGBTQ patients requires cultural humility and specific medical knowledge